Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,420 | 65,446 | 40,394 | 31,144 | 36,439 |
| Marketable Securities | 49,519 | N/A | 12,057 | 2,522 | 30,599 |
| Receivables | 15,387 | N/A | N/A | N/A | 13,679 |
| Inventories | 733 | N/A | N/A | N/A | N/A |
| TOTAL | $99,396 | $68,379 | $54,325 | $35,580 | $82,492 |
| Non-Current Assets | |||||
| PPE Net | N/A | 176 | 719 | 1,235 | 1,793 |
| Intangibles | 23,226 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,303 | 3,879 | 3,197 | 9,465 | 5,547 |
| TOTAL | $26,529 | $4,055 | $3,916 | $10,700 | $7,340 |
| Total Assets | $125,925 | $72,434 | $58,241 | $46,280 | $89,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,943 | 47,380 | 4,455 | 4,812 | 4,812 |
| Accounts payable and accrued liabilities | 2,008 | 3,891 | 1,637 | 0 | 4,498 |
| Accrued Expenses | 29,402 | 12,720 | 7,191 | 11,606 | 12,852 |
| Other current liabilities | 1,781 | 2,660 | 3,755 | 2,070 | 893 |
| TOTAL | $81,134 | $66,651 | $17,038 | $18,488 | $23,055 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,134 | 0 | N/A | 4,455 | 9,267 |
| Other Non-Current Liabilities | 1,234 | 2,016 | 1,174 | 5,404 | 4,603 |
| TOTAL | $62,368 | $2,016 | $1,174 | $9,862 | $13,838 |
| Total Liabilities | $143,502 | $68,667 | $18,212 | $28,350 | $36,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,836 | 99,918 | 76,687 | 73,679 | 57,980 |
| Common Shares | 131 | 100 | 76 | 58 | 58 |
| Retained earnings | -2,518,907 | -2,425,915 | -2,328,007 | -2,275,556 | -2,224,746 |
| Other shareholders' equity | -35 | 0 | 2 | -5,758 | -16,398 |
| TOTAL | $-17,577 | $3,767 | $40,029 | $17,930 | $52,939 |
| Total Liabilities And Equity | $125,925 | $72,434 | $58,241 | $46,280 | $89,832 |